LAS 41004

Almirall, S.A. · Phase 2 active Small molecule

At a glance

Generic name	LAS 41004
Sponsor	Almirall, S.A.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque Test (PHASE2)
Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis (PHASE2)
Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LAS 41004 CI brief — competitive landscape report
LAS 41004 updates RSS · CI watch RSS
Almirall, S.A. portfolio CI